ArticleJIMD reports2026
Are Functional Brain Networks Sensitive to High Phenylalanine in Adults With Phenylketonuria?
Article in JIMD reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In early-treated adults with phenylketonuria (PKU), the effects of elevated phenylalanine (Phe) on functional brain networks remain poorly understood. While subacute structural brain changes have been reported, their functional significance remains unclear. Executive and attentional functions have been shown to be particularly sensitive to metabolic control in PKU. In this double-blind, randomized, placebo-controlled crossover trial, we investigated the effects of a 4-week high-Phe period on resting-state functional connectivity using seed-based analyses of the dorsal attention and frontoparietal networks, which are critically involved in executive and attentional functions. Twenty-three adults with PKU (median age 35.3 years [IQR 12.0]; 43% female) were included. When baseline connectivity was considered, no significant differences in functional connectivity were observed between the Phe and placebo periods. Without baseline adjustment, exploratory analyses revealed increased functional connectivity of the right frontal eye field within the dorsal attention network with frontal regions. Changes in functional connectivity were neither associated with changes in metabolite concentrations nor in working memory, attention, or executive function. These findings suggest that subacute increases in Phe may induce subtle and potentially transient changes in functional brain networks, although their functional relevance and persistence over longer exposure periods remain unclear.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.